In the last trading session, 28.01 million Mustang Bio Inc (NASDAQ:MBIO) shares changed hands as the company’s beta touched 2.17. With the company’s per share price at $2.05 changed hands at $1.09 or 114.64% during last session, the market valuation stood at $8.97M. MBIO’s last price was a discount, traded about -1412.2% off its 52-week high of $31.00. The share price had its 52-week low at $0.95, which suggests the last value was 53.66% up since then. When we look at Mustang Bio Inc’s average trading volume, we note the 10-day average is 2.98 million shares, with the 3-month average coming to 411.96K.
Analysts gave the Mustang Bio Inc (MBIO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MBIO as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Mustang Bio Inc (NASDAQ:MBIO) trade information
Instantly MBIO was in green as seen at the end of in last trading. With action 89.81%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -91.19%, with the 5-day performance at 89.81% in the green. However, in the 30-day time frame, Mustang Bio Inc (NASDAQ:MBIO) is 56.49% up. Looking at the short shares, we see there were 3845.0 shares sold at short interest cover period of 0.04 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 51.52%.
MBIO Dividends
Mustang Bio Inc is expected to release its next quarterly earnings report on 2025-Mar-28.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.94% of Mustang Bio Inc shares while 6.88% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.73%. There are 6.88% institutions holding the Mustang Bio Inc stock share, with UBS GROUP AG the top institutional holder. As of 2024-06-30, the company held 0.0445% of the shares, roughly 0.19 million MBIO shares worth $91561.0.
KOSS-OLINGER CONSULTING, LLC holds the second largest percentage of outstanding shares, with 0.0226% or 98366.0 shares worth $47000.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 11.78 shares estimated at $24144.0 under it, the former controlled 0.33% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.08% of the shares, roughly 2.88 shares worth around $5895.0.
